• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Dime Bancorp

Dime Bancorp

  1. pSivida Corp. Reports Positive Regulatory Outcome for ILUVIEN®; Moves to National Phase for Marketing Authorizations in 10 More EU Countries

    pSivida Corp. Reports Positive Regulatory Outcome for ILUVIEN®; Moves to National Phase for Marketing Authorizations in 10 More EU Countries

  2. iCo Therapeutics Announces Director Election Results From Its Annual Meeting of Shareholders

    iCo Therapeutics Announces Director Election Results From Its Annual Meeting of Shareholders

  3. EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union

    EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.